REVIEWS
Migraine prevention
1 Professor of Neurology, Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona, USA
2 Professor of Neurology, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Correspondence to:
Professor D W Dodick, Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, USA; Dodick.David{at}mayo.edu
Preventive medications reduce migraine frequency and severity, and improve migraine-specific quality of life. Recent evidence also suggests that these same medications enhance the patients response to acute migraine therapies, and may also reduce the likelihood of developing chronic daily headache. However, many patients who should receive or be offered preventive treatment are not. Most patients can be successfully managed when patient and physician expectations are realistic and aligned, the selection of preventive medications is individualised, and the initiation and titration strategy is appropriate and carefully followed. Rational combinations of preventive medications may also be useful. This review provides an evidence and experience-based approach to the preventive treatment of migraine. ...[End of Extract]
[PDF of this article]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
